Oxford Instruments expects adjusted operating profit for FY26 to land in line with its £5.5 million market expectations.

In Q3, order intake in its imaging & analysis division rose 2.4% on an organic constant currency basis, while advanced technologies continued to outperform with year-to-date orders up 44.5%, extending order book coverage well into FY27.

The group also completed the sale of its NanoScience business in early January, generating £48.5m of net cash proceeds.

Alongside this, Oxford Instruments said its pension contributions have now stopped and it is progressing with its £100m share buyback programme, with £41.2m of the first £50m tranche completed by the end of December.